Efficacy of Topical Steroidal Treatment and Hand-Care Modification in Chronic Paronychia: A Retrospective Study

Efficacy of Topical Steroidal Treatment and Hand-Care Modification in Chronic Paronychia: A Retrospective Study

Authors

  • Eran Galili Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel https://orcid.org/0000-0003-1518-6875
  • Avner Shemer Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel
  • Lee Magal Prof Shemer Clinic, Netanya, Israel
  • Anna Lyakhovitsky Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel
  • Riad Kassem Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel
  • Baruch Kaplan Adelson School of Medicine, Ariel University, Ariel, Israel

Keywords:

chronic paronychia, corticosteroids, candida

Abstract

Introduction: Chronic paronychia is a persistent inflammatory condition of the periungual tissue, often triggered by excessive hand exposure to irritants. Despite its high prevalence, treatment remains challenging, with conflicting evidence on the role of microbial colonization, particularly Candida spp., and the efficacy of antifungal and antibiotic therapies.

Objectives: To assess the efficacy of topical corticosteroids combined with hand-care modifications and antimicrobial treatments in managing chronic fingernail paronychia.

Methods: This retrospective study included 97 patients (mean age 54.3 ±10.6 years, 67% female) with chronic fingernail paronychia (mean disease duration 13.3 ±6.1 years). Patients initially received antifungal and/or antibacterial therapy, followed by corticosteroid-based treatment and strict hand-care modifications.

Results: Microbial cultures identified Candida spp. in 95.9% and bacteria in 36.1% of cases. First-line antifungal and/or antibiotic therapy was largely ineffective (76.3% nonresponders). In contrast, second-line corticosteroid-based therapy (mean duration 4.0 ±0.7 months) led to improvement in 90.7% of cases, with 38.1% achieving complete or near-complete resolution. Hand-care modifications included minimizing prolonged contact with liquids, wearing non-powdered waterproof gloves for wet tasks, using mild fragrance-free cleansers, and applying moisturizer after handwashing. Treatment adherence, including these behavioral modifications (P<0.01) and regular topical application (P<0.001) as well as longer treatment duration (P<0.05), were significantly associated with improved outcome.

Conclusions: Chronic paronychia is primarily inflammatory, with limited response to antifungals or antibiotics. Prolonged corticosteroid-based therapy combined with hand-care modifications is highly effective, emphasizing the critical role of adherence to achieving clinical improvement.

References

Leggit JC. Acute and chronic paronychia. Am Fam Physician. 2017;96(1):44-51. PMID: 28671378.

Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol. 2014;59(1):15-20. DOI:10.4103/0019-5154.123482

Iorizzo M. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin. 2015;33(2):175-183. DOI:10.1016/j.det.2014.12.001

Rocha BP, Verardino G, Leverone A, et al. Histopathological analysis of chronic paronychia. Int J Dermatol. 2023;62(4):514-517. DOI:10.1111/ijd.16564

Bahunuthula RK, Thappa DM, Kumari R, Singh R, Munisamy M, Parija SC. Evaluation of role of Candida in patients with chronic paronychia. Indian J Dermatol Venereol Leprol. 2015;81(5):485-490. DOI:10.4103/0378-6323.158635

Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47(1):73-76. DOI:10.1067/mjd.2002.122191

Rigopoulos D, Gregoriou S, Belyayeva E, Larios G, Kontochristopoulos G, Katsambas A. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol. 2009;160(4):858-860. DOI:10.1111/j.1365-2133.2008.08988.x

Ferreira Vieira d’Almeida L, Papaiordanou F, Araújo Machado E, Loda G, Baran R, Nakamura R. Chronic paronychia treatment: Square flap technique. J Am Acad Dermatol. 2016;75(2):398-403. DOI:10.1016/j.jaad.2016.02.1154

Pabari A, Iyer S, Khoo CT. Swiss roll technique for treatment of paronychia. Tech Hand Up Extrem Surg. 2011;15(2):75-77. DOI:10.1097/BTH.0b013e3181ec089e

Shemer A, Daniel R, Lyakhovitsky A, et al. Clinical significance of Candida isolation from dystrophic fingernails. Mycoses. 2020;63(9):964-969. DOI:10.1111/myc.13133

Daniel CR, Iorizzo M, Piraccini BM, Tosti A. Grading simple chronic paronychia and onycholysis. Int J Dermatol. 2006;45(12):1447-1448. DOI:10.1111/j.1365-4632.2006.03128.x

Downloads

Published

2026-04-30

How to Cite

1.
Galili E, Shemer A, Magal L, Lyakhovitsky A, Kassem R, Kaplan B. Efficacy of Topical Steroidal Treatment and Hand-Care Modification in Chronic Paronychia: A Retrospective Study. Dermatol Pract Concept. 2026;16(2):6123. doi:10.5826/dpc.1602a6123

Share